1.Anti-Proteinuric Effect of Sulodexide in Immunoglobulin A Nephropathy.
Kitae BANG ; Ho Jun CHIN ; Dong Wan CHAE ; Kwon Wook JOO ; Yon Su KIM ; Suhnggwon KIM ; Kyung Don JU ; Hwajung KIM ; Curie AHN ; Kook Hwan OH
Yonsei Medical Journal 2011;52(4):588-594
PURPOSE: We conducted a multi-center randomized double-blind study to determine the effects of 6-month therapy with sulodexide on urinary protein excretion in patients with idiopathic Immunoglobulin A (IgA) nephropathy. MATERIALS AND METHODS: A total of seventy-seven patients participated in the study. They were randomly allocated to one of three groups: sulodexide 75 mg or 150 mg daily or the placebo for 6 months. The primary end point was the achievement, at 6 months, of at least 50% reduction in urine protein/creatinine ratio (UPCR) from the baseline value. RESULTS: At 6 months, the primary end point was achieved by 12.5% of the patients assigned to the placebo, 4.0% of the patients assigned to sulodexide 75 mg daily and 21.4% of those assigned to 150 mg (p=0.308). Treatment with sulodexide 150 mg daily for 6 months significantly reduced log UPCR from 6.38+/-0.77 at baseline to 5.98+/-0.94 at 6 months (p=0.045), while treatment with sulodexide 75 mg daily and placebo did not. CONCLUSION: A 6-month treatment with sulodexide did not achieve 50% reduction of urinary protein excretion in IgA nephropathy patients, but showed a tendency to increase the time-dependent anti-proteinuric effect. Therefore, long-term clinical trials on a larger scale are warranted to elucidate the hypothesis that sulodexide affords renal protection in IgA nephropathy patients.
Adult
;
Anticoagulants/*therapeutic use
;
Double-Blind Method
;
Female
;
Glomerulonephritis, IGA/complications/*drug therapy
;
Glycosaminoglycans/*therapeutic use
;
Humans
;
Male
;
Middle Aged
;
Proteinuria/complications/*drug therapy
2.A clinical study of topical mucopolysaccharides and polydeoxyribonucleoprotein (Foltene) therapy in alopecia.
Kyung Sin LEE ; Ki Bum MYUNG ; Hong Il KOOK
Journal of Korean Medical Science 1987;2(3):157-165
We performed clinical trials to evaluate the therapeutic effects of Foltene in patients of the several types of hair fallings. Thirty patients with male pattern baldness, alopecia areata and seborrheic alopecia were included in this study. Foltene was applied every other day for 40 days, and followed by maintenance therapy of twice application a week. The duration of whole therapy was 6 months. We conclude that Foltene is an effective and agent for male pattern baldness, alopecia areata and seborrheic alopecia from the following results. Ten patients with male pattern baldness was treated with Foltene for 6 months. Foltene had therapeutic effects of 50% in hair regrowth, 70% in decreased hair falls, 30% in decreased dandruff, 50% in decreased seborrhea. Thirteen patients with alopecia areata was treated with Foltene for 6 months. Foltene had therapeutic effects of 61.6% in hair regrowth, 53.9% in decreased in hair falls, 53.9% in decreased dandruff, 77.0% in decreased seborrhea. Seven patients with seborrheic alopecia was treatment with Foltene for 6 months. Foltene had therapeutic effects of 85.8% in hair regrowth, 57.2% in decreased hair falls, 42.9% in decreased dandruff, 85.8% in decreased seborrhea. The degree of therapeutic success was related to the duration of therapy. The side effects were as followed: itching sensation developed in 2 patients (6.7%); tingling sensation in 3 patients (10.0%); burning sensation in 1 patient (3.3%); erythema in 3 patients (10.0%).
Administration, Topical
;
Adolescent
;
Adult
;
Alopecia/*drug therapy/genetics
;
Child
;
Child, Preschool
;
Deoxyribonucleoproteins/*therapeutic use
;
Female
;
Glycosaminoglycans/adverse effects/*therapeutic use
;
Humans
;
Male
3.Effects of alligator Zhikegao on relieving cough dispelling phlegm and anti-inflammation.
Dong-Hui XU ; Zhao-Zhang LUO ; Xue-Ting MEI ; Hai-Ping MA ; Jun-Ling ZENG ; Shi-Bo XU
China Journal of Chinese Materia Medica 2007;32(10):961-965
OBJECTIVETo research the effects of Alligator Zhikegao on relieving cough, dispelling phlegm and anti-inflammation.
METHODThe coughing tests in mice, the phenol red secreting tests in mice, ear edema tests in mice,and paw edema tests and subcutaneous cotton ball granuloma in rats were adopted for observing the related pharmacological effects of Alligator Zhikegao.
RESULTAlligator Zhikegao could obviously prolong the latent period and decrease the times of mouse coughing, and remarkably inhibit the mouse ear edema (P < 0.001), the rat paw edema and the hyperplasia of subcutaneous cotton ball granuloma in rats. Alligator Zhikegao 11.70 g x kg(-1) could significant improve the carbonic clearances of macrophages (P <0.05) and the hemolysin level in serum (P <0.01).
CONCLUSIONAlligator Zhikegao has significant effects on relieving cough, dispelling phlegm, anti-inflammation and immunological regulation.
Alligators and Crocodiles ; Animals ; Anti-Inflammatory Agents, Non-Steroidal ; isolation & purification ; therapeutic use ; Antitussive Agents ; isolation & purification ; therapeutic use ; Cough ; drug therapy ; Drug Combinations ; Drugs, Chinese Herbal ; isolation & purification ; therapeutic use ; Ear Diseases ; drug therapy ; Edema ; drug therapy ; Expectorants ; isolation & purification ; therapeutic use ; Female ; Glycosaminoglycans ; isolation & purification ; therapeutic use ; Granuloma ; drug therapy ; Male ; Materia Medica ; isolation & purification ; therapeutic use ; Medicine, Chinese Traditional ; Mice ; Plants, Medicinal ; chemistry ; Random Allocation ; Rats ; Rats, Sprague-Dawley
4.Renal protective effects of sulodexide in diabetic rats and its anti-oxidative mechanism.
Jiong SHU ; Long-yi ZENG ; Ke-yi LIN ; Pan-wei MU ; Guo-chao ZHANG ; Yan-ming CHEN ; Man-man WANG
Journal of Southern Medical University 2009;29(4):778-780
OBJECTIVETo investigate the renal protective effects of sulodexide and its anti-oxidative stress mechanism in diabetic rats.
METHODThirty male SD rats were randomized into 3 equal groups, namely the control group, diabetic group, and sulodexide treatment group. Twelve weeks after establishment of rat diabetic models and administration of sulodexide, the rats were sacrificed for measurement of the urine volume, body mass, kidney mass/body weight ratio, plasma glucose, and glycosylated hemoglobin (HbA1c). Malondialdehyde (MDA) levels and superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-PX) activities in the renal tissue or serum were tested. Electron microscopy was performed to observe the pathological changes in the kidneys.
RESULTSThe urine volume, renal mass/body mass ratio, serum glucose, HbA1C, and serum and renal MDA levels all significantly increased in the diabetic rats in comparison with the normal controls (P<0.05). But the body weight and activities of SOD, CAT, and GSH-PX in the renal tissue in the normal control group were significantly higher than those in the diabetic and sulodexide group. After 12 weeks of sulodexide treatment, SOD, CAT, and GSH-PX activities in the renal tissue of rats were significantly increased in comparison with those in the diabetic rats (P<0.05). Electron microscopy showed obvious irregular thickening of the glomerular capillary basement membrane in the diabetic group with vacuolization in the mitochondria in the epithelial cells, and such pathological changes were significantly alleviated in the sulodexide treatment group.
CONCLUSIONSSulodexide can effectively lower the urinary albumin excretion rate, improve the ultrastructural renal pathologies and prevent glomerular basement membrane thickening in diabetic rats, probably in association with the reduction of the MDA levels and enhancement of SOD, CAT, and GSH-PX activities.
Animals ; Antioxidants ; pharmacology ; therapeutic use ; Body Weight ; drug effects ; Catalase ; metabolism ; Diabetes Mellitus ; drug therapy ; metabolism ; pathology ; Glutathione Peroxidase ; metabolism ; Glycosaminoglycans ; pharmacology ; therapeutic use ; Kidney ; drug effects ; metabolism ; pathology ; Male ; Malondialdehyde ; metabolism ; Organ Size ; drug effects ; Rats ; Rats, Sprague-Dawley ; Superoxide Dismutase ; metabolism